Christianson Mark's Form 4 filing
Neuroone Medical Technologies Corp (NMTC) · filed Apr 1, 2026
- Accession no.
- 0001709738-26-000009
- Filed
- Apr 1, 2026
- Trade date
- Mar 30-31, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $11.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Christianson MarkCIK 0001709738 | Officer (Business Development Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | Common Stock | SSaleDisposed | −15,363 | $0.74 | −$11,368.62 | 198,920 | Direct | |
| Mar 31, 2026 | Common Stock | FTax withholdingDisposed | −253 | $0.78 | −$197.34 | 198,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.